COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. New York patients with a documented clinical need may be eligible for compounded tirzepatide.
New York has one of the largest and most regulated pharmacy networks in the country, with strong compounding options in NYC, Long Island, and upstate cities. Compounding Finder helps New York residents compare licensed pharmacies statewide.
Yes. The New York State Education Department oversees pharmacy compounding. A valid prescription with clinical justification is required.
Typically $150 to $450 per month.
.png){kind=spacer}
